Eligible patients can save with MOVANTIK

With the MOVANTIK Savings Card, eligible commercially insured patients can save on their MOVANTIK prescription and receive it for less than the cost of OTC laxatives.*

Access the MOVANTIK
Savings Card
Savings Card
*Subject to complete eligibility rules; restrictions apply. OTC laxatives include Colace®, Dulcolax®, ex-lax®, MiraLAX®, and Senokot®. Product names are registered trademarks of their respective owners. Pricing comparisons do not imply comparable efficacy, safety, or FDA-approved indications.

PATIENT INSTRUCTIONS: Present this offer to your pharmacist along with a valid prescription for MOVANTIK® (naloxegol) Tablets. Please call 312-896-0135 with questions and for full eligibility details.

TERMS AND CONDITIONS: Offer good for patients who meet eligibility criteria purchasing a 30-, 60-, or 90-day supply. Eligible commercially insured patients will pay as little as $0 for their monthly prescription, subject to a maximum benefit limit. Eligible uninsured (cash-paying) patients will receive savings on eligible out-of-pocket costs subject to a maximum benefit limit.

This program provides eligible patients with assistance to reduce out-of-pocket costs. By using this offer, patient and pharmacist understand and agree to comply with these terms and conditions. Only eligible U.S. residents may use this offer at participating pharmacies and may not redeem this offer at government-subsidized clinics. Offer user must be at least 18 years of age to use for themselves or on behalf of a minor. Patient age or insurance restrictions may apply.

Restrictions: No substitutions are permitted. Offer eligible only with valid prescription, has no cash value, and cannot be combined with any free trial, discount, prescription savings card, or other offer. This offer is not insurance. Valid only for patients with commercial insurance. This offer is NOT valid for prescriptions eligible to be reimbursed in whole or in part by Medicaid, Medicare (including Medicare Advantage and Part D plans), Veterans Affairs (VA), Department of Defense (DOD) programs or TriCare, or any other federally or state funded healthcare benefit program, or by commercial plans or health or pharmacy benefit programs that reimburse for the entire cost of the prescription drug or prohibit offer’s use. Medicare Part D enrollees who are in the prescription drug coverage gap are not eligible for offer. This offer is not transferable and is limited to one offer per person. Void were prohibited by law, taxed, or restricted. It is illegal to sell, purchase, trade, or counterfeit, or offer to sell, purchase, trade, or counterfeit the offer.

Valinor Pharma, LLC, reserves the right to rescind, revoke, or amend the offer at any time without notice.

Pharmacist instruction for a patient with an eligible Third-Party Payer: Submit the claim to the primary Third-Party Payer first, then submit the balance due as a Secondary Payer using Secondary Payer COB [coordination of benefits] with patient responsibility amount and a valid Other Coverage Code (eg, 8 or 3).

Pharmacist instruction for a cash-paying patient: Submit this claim as a Primary Payer using a valid Other Coverage Code (eg, 1).

For any questions regarding online processing, call the Pharmacy Help Desk at 312-896-0147.


MOVANTIK is a prescription medicine used to treat constipation that is caused by prescription pain medicines called opioids, in adults with long-lasting (chronic) pain that is not caused by active cancer.

  • MOVANTIK may cause serious side effects, including:
    • Opioid withdrawal. You may have symptoms of opioid withdrawal during treatment with MOVANTIK, including sweating, chills, diarrhea, stomach pain, anxiety, irritability, and yawning. If you take methadone to treat your pain, you may be more likely to have stomach pain and diarrhea than people who do not take methadone. Tell your healthcare provider if you have any of these symptoms
    • Severe stomach (abdominal) pain and/or diarrhea. Severe stomach pain and diarrhea can happen when you take MOVANTIK. These problems can happen within a few days after you start taking MOVANTIK and can lead to hospitalization. Stop taking MOVANTIK and call your healthcare provider right away if you have severe stomach pain or diarrhea, or both severe stomach pain and diarrhea
    • Tear in your stomach or intestinal wall (perforation). Stomach pain that is severe can be a sign of a serious medical condition. If you get stomach pain that gets worse or does not go away, stop taking MOVANTIK and get emergency medical help right away
  • Do not take MOVANTIK if you:
    • Have a bowel blockage (intestinal obstruction) or have a history of bowel blockage
    • Are allergic to MOVANTIK or any of the ingredients in MOVANTIK
  • MOVANTIK can interact with certain other medicines and cause side effects, including opioid withdrawal symptoms such as sweating, chills, diarrhea, stomach pain, anxiety, irritability, and yawning. Tell your healthcare provider or pharmacist before you start or stop any medicines during treatment with MOVANTIK
  • Before you take MOVANTIK, tell your doctor about all of your medical conditions, including if you:
    • Have any stomach or bowel (intestines) problems, including inflammation in parts of the large intestine (diverticulitis), or inflammation and injury of the intestines caused by reduced blood flow (ischemic colitis), or cancer of the stomach or bowel
    • Have had recent surgery on the stomach or intestines
    • Have any kidney or liver problems
    • Are pregnant or plan to become pregnant. Taking MOVANTIK during pregnancy may cause opioid withdrawal symptoms in you or your unborn baby. Tell your healthcare provider right away if you become pregnant during treatment with MOVANTIK
    • Are breastfeeding or plan to breastfeed. It is not known if MOVANTIK passes into your breast milk. Taking MOVANTIK while you are breastfeeding may cause opioid withdrawal in your baby. You and your healthcare provider should decide if you will take MOVANTIK or breastfeed. You should not breastfeed if you take MOVANTIK
  • Tell your doctor about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Other medicines may affect the way MOVANTIK works
  • Especially tell your healthcare provider if you take a medicine called bevacizumab
  • Tell your healthcare provider if you stop taking your opioid pain medicine. If you stop taking your opioid pain medicine, you should also stop taking MOVANTIK
  • Avoid eating grapefruit or drinking grapefruit juice during treatment with MOVANTIK
  • The most common side effects of MOVANTIK include: stomach (abdomen) pain, diarrhea, nausea, gas, vomiting, headache, and excessive sweating. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of MOVANTIK
  • It is not known if MOVANTIK is safe and effective in children

You may report side effects to Valinor Pharma at 1-877-592-2337 or FDA at 1-800-FDA-1088 or

Click here for the Medication Guide and full Prescribing Information for MOVANTIK.

Valinor Pharma, LLC, supports the responsible use of medications, including those containing opioids, as treatment options for patients with chronic non-cancer pain.

This site is intended for US Consumers only.

The information on this website should not take the place of talking with your doctor or health care professional. If you have any questions about your condition, or if you would like more information about MOVANTIK, or about constipation caused by opioid use for chronic non-cancer pain, talk to your doctor or pharmacist. Only you and your doctor can decide if MOVANTIK is right for you.

The information on the following site is intended for US healthcare professionals. Please choose:

I am not a US healthcare professional


I am a US healthcare professional


Think you have opioid-induced constipation?

Think you have opioid-induced constipation?

Begin the quiz

Are you currently taking any opioid pain medication(s) for chronic non-cancer pain?

Select one

Not sure

MOVANTIK is meant for people taking opioids in order to treat opioid-induced constipation in adults with chronic non-cancer pain.

If you’re experiencing constipation, talk to your doctor about your options for treatment.2,3

Go back

How many bowel movements do you have per week?

Select one

4 or more

MOVANTIK is for the treatment of opioid-induced constipation in adults with chronic non-cancer pain. Having less than 3 bowel movements per week while taking opioids can be a symptom of opioid-induced constipation.

If you’re experiencing constipation, talk to your doctor
about your options for treatment.2,3

Go back

When completing a bowel movement, have you experienced any of the following?

Select all that apply

Hard or lumpy
Sense of incomplete evacuation

You may have opioid-induced constipation.1-3

Talk to you doctor about your symptoms and learn how
MOVANTIK may be able to help.

References: 1. Brock C, Olesen SS, Olesen AE, Frøkjaer JB, Andresen T, Drewes AM. Opioid-induced bowel dysfunction: pathophysiology and management. Drugs. 2012;72:1847-1865. 2. MOVANTIK® (naloxegol). Prescribing information. Valinor Pharma, LLC; 2023. 3. Chey WD, Webster L, Sostek M, Lappalainen J, Barker PN, Tack J. Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med. 2014;370:2387-2396.

Coverage for the #1 prescribed oral
PAMORA just got even better1

*Data as of June 2021.3

Plans and coverage may vary and are subject to change. General information only, not a guarantee of coverage. Coverage and status do not imply efficacy or safety.

PAMORA=peripherally acting mu-opioid receptor antagonist; PDP=prescription drug plan.

References: 1. Data on file. Prescription data. Valinor Pharma, LLC; 2023. 2. Data on file. Prime Therapeutics formulary coverage. Valinor Pharma, LLC; 2023. 3. Data on file. Cigna formulary coverage. Valinor Pharma, LLC; 2023.


  • MOVANTIK® (naloxegol) is contraindicated in:
    • Patients with known or suspected gastrointestinal (GI) obstruction and patients at risk of recurrent obstruction, due to the potential for GI perforation
    • Patients receiving strong CYP3A4 inhibitors (eg, clarithromycin, ketoconazole) because these medications can significantly increase exposure to naloxegol which may precipitate opioid withdrawal symptoms

Click here for additional Important Safety Information and full Prescribing Information for MOVANTIK.